Clinical Trials-Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver Cancer-Liver Cancer

To evaluate the safety and efficacy of ultrasonography (US) -guided radiofrequency ablation for liver tumors, the investigators used preoperative and postoperative US/CEUS(contrast-enhanced ultrasonography)/CT/MRI to assess lesions, and laboratory tests including the tumor markers to evaluate the general condition of patients. Intraoperative US/CEUS/CT would be applied to monitor ablation lesions.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 400 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : January 2013
Estimated Primary Completion Date : January 2018
Estimated Study Completion Date : December 2018
Contact: Tian’an Jiang, Phd    +86 18857127666    tiananjiang@126.com
Contact: Guo Tian, Master    +86 13600529967    871035504@qq.com
Locations
China, Zhejiang
The First Affiliated Hospital of Zhejiang University Recruiting
Hangzhou, Zhejiang, China, 310003

ClinicalTrials.gov Identifier: NCT03026452
* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.